ADENOSINE
ADENOSINE · PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
MYLAN INST-NOVA
Drug class
Adenosine
Adenosine is a specific active drug moiety and endogenous purine nucleoside rather than an independent therapeutic drug class; in regulatory and pharmacological classification systems such as the FDA Established Pharmacologic Class index, it is categorized as an adenosine receptor agonist and classified clinically among miscellaneous antiarrhythmics. Read more about Adenosine
12 drugs in this class 9 manufacturers
Drugs in Adenosine
Filter & compare in the drug finder →
Opens the drug finder with Adenosine preselected. Add indication or manufacturer filters there.
Adenosine is a specific active drug moiety and endogenous purine nucleoside rather than an independent therapeutic drug class; in regulatory and pharmacological classification systems such as the FDA Established Pharmacologic Class index, it is categorized as an adenosine receptor agonist and classified clinically among miscellaneous antiarrhythmics.
Pharmacologically, it stimulates cardiac A1 adenosine receptors to inhibit adenylate cyclase, slow atrioventricular nodal conduction time, and disrupt nodal re-entrant pathways, while also activating vascular A2A receptors to produce potent coronary vasodilation.
Therapeutically, it is indicated for the acute conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm and as a pharmacologic stressor during myocardial perfusion imaging to assess coronary artery disease.
-
fda.gov
Adenosine is a specific active drug moiety and endogenous purine nucleoside rather than an independent therapeutic drug class; in regulatory and pharmacological classification systems such as the FDA Established Pharmacologic Class index, it is categorized as an adenosine receptor agonist and classified clinically among miscellaneous antiarrhythmics
-
fda.gov
Adenosine is a specific active drug moiety and endogenous purine nucleoside rather than an independent therapeutic drug class; in regulatory and pharmacological classification systems such as the FDA Established Pharmacologic Class index, it is categorized as an adenosine receptor agonist and classified clinically among miscellaneous antiarrhythmics
-
ndclist.com
Adenosine is a specific active drug moiety and endogenous purine nucleoside rather than an independent therapeutic drug class; in regulatory and pharmacological classification systems such as the FDA Established Pharmacologic Class index, it is categorized as an adenosine receptor agonist and classified clinically among miscellaneous antiarrhythmics
-
fda.gov
Pharmacologically, it stimulates cardiac A1 adenosine receptors to inhibit adenylate cyclase, slow atrioventricular nodal conduction time, and disrupt nodal re-entrant pathways, while also activating vascular A2A receptors to produce potent coronary vasodilation Therapeutically, it is indicated for the acute conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm and as a pharmacologic stressor during myocardial perfusion imaging to assess coronary artery disease
-
fda.gov
Pharmacologically, it stimulates cardiac A1 adenosine receptors to inhibit adenylate cyclase, slow atrioventricular nodal conduction time, and disrupt nodal re-entrant pathways, while also activating vascular A2A receptors to produce potent coronary vasodilation
-
nih.gov
Pharmacologically, it stimulates cardiac A1 adenosine receptors to inhibit adenylate cyclase, slow atrioventricular nodal conduction time, and disrupt nodal re-entrant pathways, while also activating vascular A2A receptors to produce potent coronary vasodilation
-
fda.gov
Therapeutically, it is indicated for the acute conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm and as a pharmacologic stressor during myocardial perfusion imaging to assess coronary artery disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.